Skip to content

AKARI THERAPEUTICS, PLC

AKTX

CIK 0001541157

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$26.46M
+12.6% YoY Q1 May 2026
EPS Diluted (TTM)
$0.00
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$13.56M
Q1 May 2026
Cash
$2.77M
Q1 May 2026
Total Debt
$200K
Q1 May 2026
Shares Outstanding
91.57B sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings